Literature DB >> 29607201

Clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients.

Xiongfei Li1, Mingbiao Li1, Tao Shi2, Renwang Liu1, Dian Ren1, Fan Yang1, Sen Wei1, Gang Chen1, Jun Chen1,3, Song Xu1,3.   

Abstract

Thymic carcinoid is a rare but very aggressive neuroendocrine tumour derived from the neuroendocrine system. Here we report a male patient with thymic atypical carcinoid. Though thymic carcinoid is relatively common, the gene sequencing profile was performed and the gene sequencing result indicated germline multiple endocrine neoplasia type 1 (MEN1) mutation and two somatic mutations on MEN1 gene and no copy number variation or fusion events were detected. It is well-known that the mutation of MEN1 is the typical manifestation of MEN1 syndrome, which is an autosome dominant disease that includes varying combinations of more than 20 endocrine and non-endocrine tumors. In the English literature, 7 cases of solitary thymic carcinoid harboring somatic variants in MEN1 are reported in the absence of other organs involvement as MEN1 syndrome presents. We summarized the clinical features and prognosis of this rare thymic tumor.

Entities:  

Keywords:  Multiple endocrine neoplasia type 1 (MEN1); next generation sequencing (NGS); prognosis; thymic carcinoid

Year:  2018        PMID: 29607201      PMCID: PMC5864637          DOI: 10.21037/jtd.2018.01.127

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  15 in total

1.  Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.

Authors:  P Ferolla; A Falchetti; P Filosso; P Tomassetti; G Tamburrano; N Avenia; G Daddi; F Puma; R Ribacchi; F Santeusanio; G Angeletti; M L Brandi
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

2.  Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.

Authors:  Fathia Gibril; Yuan-Jia Chen; David S Schrump; Alexander Vortmeyer; Zhengping Zhuang; Irina A Lubensky; James C Reynolds; Adeline Louie; Laurence K Entsuah; Kane Huang; Behnam Asgharian; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

3.  Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases.

Authors:  J Rosai; E Higa
Journal:  Cancer       Date:  1972-04       Impact factor: 6.860

Review 4.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

5.  Simultaneous double thymic carcinoids: a rare initial manifestation of multiple endocrine neoplasia type 1.

Authors:  Ryutaro Kikuchi; Nobuya Mino; Taku Okamoto; Tadashi Matsukura; Takashi Hirai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-01-12

6.  Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1.

Authors:  Ali A Ghazi; Azizollah Abbasi Dezfooli; Farzaneh Mohamadi; Seyed Vahid Yousefi; Alireza Amirbaigloo; Siavash Ghazi; Marina Pourafkari; Dan Berney; Sian Ellard; Ashley B Grossman
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

7.  Ectopic Cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation.

Authors:  Shirin Hasani-Ranjbar; Masoud Rahmanian; Azadeh Ebrahim-Habibi; Akbar Soltani; Akbar Soltanzade; Elnaz Mahrampour; Mahsa M Amoli
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

8.  Ectopic growth hormone-releasing hormone secretion by thymic carcinoid tumour.

Authors:  E Boix; A Picó; R Pinedo; I Aranda; K Kovacs
Journal:  Clin Endocrinol (Oxf)       Date:  2002-07       Impact factor: 3.478

9.  Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1).

Authors:  S J Marx; S K Agarwal; M B Kester; C Heppner; Y S Kim; M R Emmert-Buck; L V Debelenko; I A Lubensky; Z Zhuang; S C Guru; P Manickam; S E Olufemi; M C Skarulis; J L Doppman; R H Alexander; L A Liotta; F S Collins; S C Chandrasekharappa; A M Spiegel; A L Burns
Journal:  J Intern Med       Date:  1998-06       Impact factor: 8.989

10.  Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2016-01-18
View more
  3 in total

1.  Erratum to clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients.

Authors: 
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

2.  Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Iina Yliaska; Heikki Tokola; Tapani Ebeling; Outi Kuismin; Olavi Ukkola; Minna L Koivikko; Timo Lesonen; Jussi Rimpiläinen; Tuuli Felin; Eeva Ryhänen; Saara Metso; Camilla Schalin-Jäntti; Pasi Salmela
Journal:  Endocrine       Date:  2022-06-13       Impact factor: 3.925

3.  Development and validation of a nomogram prognostic model for patients with neuroendocrine tumors of the thymus.

Authors:  Jia-Yu Tang; Hui-Jiang Gao; Guo-Dong Shi; Xiao-Kang Guo; Wen-Quan Yu; Hua-Feng Wang; Yu-Cheng Wei
Journal:  Thorac Cancer       Date:  2020-07-12       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.